CH EPL (R5)
0.1.0 - ci-build

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 IDMP Standard ISO 11615
... 3 Datasource Authorised Medicinal Product
... 4 Dataexport FOPH Spezialitätenliste
... 5 Use Cases
... 6 Cuprior
... 7 Entocort
... 8 Estalis
... 9 Keytruda
... 10 Paxlovid
... 11 Triogen
... 12 Profiles
... 13 Extensions
... 14 Terminology
... 15 Artifacts Summary
.... 15.1 CH EPL Organization
.... 15.2 CH IDMP AdministrableProductDefinition
.... 15.3 CH IDMP ClinicalUseDefinition Indication
.... 15.4 CH IDMP DocumentReference
.... 15.5 CH IDMP ManufacturedItemDefinition
.... 15.6 IDMP Bundle
.... 15.7 IDMP Ingredient
.... 15.8 IDMP MedicinalProductDefinition
.... 15.9 IDMP PackagedProductDefinition
.... 15.10 IDMP RegulatedAuthorization
.... 15.11 FOPH Dossier Number
.... 15.12 GLN Identifier
.... 15.13 LOC Identifier
.... 15.14 CH - EPL Full Limitation Text
.... 15.15 CH - EPL Product Price
.... 15.16 CH - EPL Regulated Authorization Limitation
.... 15.17 CH - EPL Reimbursement SL
.... 15.18 CH - SMC Authorized Dose Form
.... 15.19 CH - Authorisation Type
.... 15.20 CH - Medicinal Product Name Type
.... 15.21 CH - Other Characteristics Type
.... 15.22 CH EPL - Gamme
.... 15.23 CH EPL - Limitation Status
.... 15.24 CH EPL - Listing Status
.... 15.25 CH EPL - Other Characteristics Packaged Item
.... 15.26 CH EPL - Price Type
.... 15.27 CH EPL - Product Type
.... 15.28 CH EPL - Reimbursement Status
.... 15.29 CH EPL - Type of Price Change
.... 15.30 CH SMC - Attached Document Type
.... 15.31 CH SMC - Authorisation Category
.... 15.32 CH SMC - Authorisation Status
.... 15.33 CH SMC - Authorised Pharmaceutical Dose Form
.... 15.34 CH SMC - Ingredient Role
.... 15.35 CH SMC - Legal Status of Supply
.... 15.36 CH SMC - Marketing Status
.... 15.37 CH SMC - Pediatric Use Indicator
.... 15.38 CH SMC - Special Precautions for Storage
.... 15.39 CH SMC - Substance
.... 15.40 CH SMC - TherapeuticProductcode
.... 15.41 CH SMC- Additional Monitoring Indicator
.... 15.42 EDQM - Combination Packaging
.... 15.43 EDQM - Combined Pharmaceutical Dose Form
.... 15.44 EDQM - Combined Term
.... 15.45 EDQM - Packaging
.... 15.46 EDQM - Pharmaceutical Dose Form
.... 15.47 EDQM - Route Of Administration
.... 15.48 EDQM - Unit of Presentation
.... 15.49 EMA - Domain
.... 15.50 EMA - Intended Effect
.... 15.51 EMA - Shelf Life Type
.... 15.52 CH - Authorisation Type
.... 15.53 CH - Medicinal Product Name Type
.... 15.54 CH - Other Characteristics Type
.... 15.55 CH EPL - Gamme
.... 15.56 CH EPL - Limitation Status
.... 15.57 CH EPL - Listing Status
.... 15.58 CH EPL - Other Characteristics Packaged Item
.... 15.59 CH EPL - Price Type
.... 15.60 CH EPL - Product Type
.... 15.61 CH EPL - Reimbursement Status
.... 15.62 CH EPL - Type of Price Change
.... 15.63 CH SMC - Additional Monitoring Indicator
.... 15.64 CH SMC - Attached Document Type
.... 15.65 CH SMC - Authorisation Category
.... 15.66 CH SMC - Authorisation Status
.... 15.67 CH SMC - Ingredient Role
.... 15.68 CH SMC - Legal Status of Supply
.... 15.69 CH SMC - Marketing Status
.... 15.70 CH SMC - Pediatric Use Indicator
.... 15.71 CH SMC - Special Precautions for Storage
.... 15.72 CH SMC - Substance
.... 15.73 CH SMC - TherapeuticProductcode
.... 15.74 EDQM - Standard Terms
.... 15.75 EMA - Domain
.... 15.76 EMA - Intended Effect
.... 15.77 EMA - Shelf Life Type
.... 15.78 5204201
.... 15.79 52042011
.... 15.80 5470402
.... 15.81 54704089
.... 15.82 66231001
.... 15.83 6623101
.... 15.84 67431001
.... 15.85 6743101
.... 15.86 67719001
.... 15.87 6771901
.... 15.88 68793001
.... 15.89 6879301
.... 15.90 CH-52042011
.... 15.91 CH-54704089
.... 15.92 CH-66231001
.... 15.93 CH-67431001
.... 15.94 CH-68291001
.... 15.95 CH-68793001
.... 15.96 CUPRIOR Filmtabl 150 mg 72 Stk
.... 15.97 CUPRIOR Filmtabl 150 mg 72 Stk (Bundle)
.... 15.98 Cuprior, Filmtabletten Fachinformation
.... 15.99 Cuprior, Filmtabletten Patienteninformation
.... 15.100 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk
.... 15.101 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk (Bundle)
.... 15.102 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Fachinformation
.... 15.103 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Patienteninformation
.... 15.104 ESTALIS Matrixpfl 50/250 24 Stk
.... 15.105 ESTALIS Matrixpfl 50/250 24 Stk (Bundle)
.... 15.106 ESTALIS Matrixpfl 50/250 24 Stk Fachinformation
.... 15.107 ESTALIS Matrixpfl 50/250 24 Stk Patienteninformation
.... 15.108 Indication 10009900
.... 15.109 Indication 10019927
.... 15.110 Indication 10021782
.... 15.111 Indication 10027400
.... 15.112 Indication 10028881
.... 15.113 Indication 10030247
.... 15.114 Indication 10031285
.... 15.115 Indication 10043971
.... 15.116 Indication 10061091
.... 15.117 Indication 10075566
.... 15.118 Indication 10084529
.... 15.119 KEYTRUDA Inf Konz 100 mg / 4 ml
.... 15.120 KEYTRUDA Inf Konz 100 mg / 4 ml (Bundle)
.... 15.121 Keytruda, Konzentrat zur Herstellung einer Infusionslösung Fachinformation
.... 15.122 Limitation 254837009
.... 15.123 Limitation 79886009
.... 15.124 Limitation 840539006
.... 15.125 MI Budesonidum-2.3mg-Tablet
.... 15.126 MI Estradiol-hemihydrate-Norethisteroni-acetas-Transdermal-patch
.... 15.127 MI Nirmatrelvir-150mg-Tablet
.... 15.128 MI Pembrolizumab-100mg-Vial
.... 15.129 MI Ritonavirum-100mg-Tablet
.... 15.130 MI Solvent
.... 15.131 MI Trientinum-150mg-Tablet
.... 15.132 MI Trientinum-250mg-Capsule
.... 15.133 PAXLOVID Filmtabl 4x150mg/2x100mg
.... 15.134 PAXLOVID Filmtabl 4x150mg/2x100mg (Bundle)
.... 15.135 Paxlovid, Filmtabletten Patienteninformation
.... 15.136 PhP Budesonidum-Suspension
.... 15.137 PhP Estradiol-hemihydrate and Norethisteroni-acetas Transdermal-patch
.... 15.138 PhP Pembrolizumab-100mg-Vial
.... 15.139 PhP Trientinum-150mg-Tablet
.... 15.140 PhP Trientinum-150mg-Tablet
.... 15.141 PhP-Nirmatrelvir-150mg-Filmcoatedtablet
.... 15.142 PhP-Ritonavirum-100mg-Filmcoatedtablet
.... 15.143 Professional Information Paxlovid, Filmtabletten Fachinformation
.... 15.144 Reimbursement SL 17418
.... 15.145 Reimbursement SL 17973
.... 15.146 Reimbursement SL 20416
.... 15.147 Reimbursement SL 21070
.... 15.148 Reimbursement SL 21208
.... 15.149 Reimbursement SL 21529
.... 15.150 TRIOGEN Kaps 250 mg Ds 100 Stk
.... 15.151 TRIOGEN Kaps 250 mg Ds 100 Stk (Bundle)
.... 15.152 Triogen, Kapseln Fachinformation
.... 15.153 Triogen, Kapseln Patienteninformation